{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:56:36Z","timestamp":1770418596953,"version":"3.49.0"},"reference-count":59,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Gynecological Endocrinology"],"published-print":{"date-parts":[[2020,7,2]]},"DOI":"10.1080\/09513590.2020.1757058","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T06:04:28Z","timestamp":1587708268000},"page":"569-577","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Ospemifene efficacy and safety data in women with vulvovaginal atrophy"],"prefix":"10.1080","volume":"36","author":[{"given":"Lino Del","family":"Pup","sequence":"first","affiliation":[{"name":"University Sanitary Agency Friuli Central","place":["Udine, Italy"]},{"name":"Board of Italian Society of Third Age Gynecology (SIGiTE)","place":["Milan, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"S\u00e1nchez-Borrego","sequence":"additional","affiliation":[{"name":"Cl\u00ednica de Atenci\u00f3n a la Mujer, DIATROS","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2014.946279"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2014.03.003"},{"issue":"10","key":"e_1_3_4_4_1","first-page":"3090","article-title":"Diagnosis and treatment of atrophic vaginitis","volume":"61","author":"Bachmann GA","year":"2000","unstructured":"Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician. 2000;61(10):3090\u20133096.","journal-title":"Am Fam Physician"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2010.08.001"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.07.045"},{"key":"e_1_3_4_7_1","first-page":"9","article-title":"Vaginal pH, estrogen and genital atrophy | menopause management","author":"Freedman MA","year":"2008","unstructured":"Freedman MA. Vaginal pH, estrogen and genital atrophy | menopause management. Menopause Manag. 2008;9\u201313.","journal-title":"Menopause Manag"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2013.871696"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2016.1240770"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2018.1529748"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2011.647840"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S158913"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000921"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.6118\/jmm.2017.23.2.79"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2010.487483"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms140714064"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4451"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000776"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2016.1218847"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.5414\/CP202821"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e3181c1ac01"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e318279ba64"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2017.6385"},{"key":"e_1_3_4_24_1","unstructured":"Drugs@FDA: FDA approved drug products: OSPHENA\u00ae (ospemifene) 60\u2009mg tablet [Internet]. [cited 2019. Nov 21]. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&varApplNo=203505."},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mjt.0000434044.39502.64"},{"key":"e_1_3_4_26_1","unstructured":"European Medicine Agency. Senshio: EPAR \u2013 Product Information. Last updated Nov 2019 [Internet]. European Medicine Agency. 2018. [cited 2019 Nov 20]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/senshio."},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000275"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000900"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/09513590410001672197"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2013.09.003"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S39146"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000624"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S110035"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2013.834493"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1332589"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001292"},{"key":"e_1_3_4_37_1","unstructured":"Nappi RE Murina F Perrone G et\u00a0al. Clinical profile of women with vulvar and vaginal atrophy who are not candidates for local vaginal estrogen therapy. Minerva Ginecol [Internet]. 2017. [cited 2019 Jun 25]; Available from: http:\/\/www.minervamedica.it\/index2.php?show=R09Y2017N04A0370"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001350"},{"issue":"1","key":"e_1_3_4_39_1","first-page":"555928","article-title":"Earlier treatment of vulvovaginal atrophy in post-menopausal women may improve treatment outcomes","volume":"16","author":"Palacios S","year":"2019","unstructured":"Palacios S, Panay N, S\u00e1nchez-Borrego R, et\u00a0al. Earlier treatment of vulvovaginal atrophy in post-menopausal women may improve treatment outcomes. J Gynecol Womens Health. 2019;16(1):555928.","journal-title":"J Gynecol Womens Health"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2018.1427717"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esxm.2018.03.002"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2018.10.009"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2014.954996"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2018.1441398"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1370645"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1323859"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2017.1284780"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2018.11.016"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.6118\/jmm.2018.24.1.1"},{"key":"e_1_3_4_50_1","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP). [Internet]. European Medicines Agency; 2014 [Nov]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/002780\/WC500182777.pdf"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000656"},{"issue":"5","key":"e_1_3_4_52_1","first-page":"555871","article-title":"Safety and efficacy of ospemifene in women with a history of breast cancer","volume":"13","author":"Bruyniks N","year":"2019","unstructured":"Bruyniks N, Pup LD, Biglia N. Safety and efficacy of ospemifene in women with a history of breast cancer. J Gynecol Women\u2019s Health. 2019;13(5):555871.","journal-title":"J Gynecol Women\u2019s Health"},{"key":"e_1_3_4_53_1","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP). Summary of opinion (initial authorisation) [Internet]. European Medicines Agency; 2014 [Nov]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Summary_of_opinion_-_Initial_authorisation\/human\/002780\/WC500177633.pdf."},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/1933719113497290"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.141.2.7342"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2018.11.017"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-006-0689-9"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7513610"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2018-000096"},{"issue":"3","key":"e_1_3_4_60_1","article-title":"Safety of ospemifene during real-life use","volume":"9","author":"Bruyniks N","year":"2018","unstructured":"Bruyniks N. Safety of ospemifene during real-life use. J Gynecol Womens Health [Internet]. 2018;9(3):555762; [cited 2019 Jun 25]. Available from: https:\/\/juniperpublishers.com\/jgwh\/JGWH.MS.ID.555762.php","journal-title":"J Gynecol Womens Health [Internet]"}],"container-title":["Gynecological Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09513590.2020.1757058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T11:27:34Z","timestamp":1770377254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09513590.2020.1757058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7,2]]}},"alternative-id":["10.1080\/09513590.2020.1757058"],"URL":"https:\/\/doi.org\/10.1080\/09513590.2020.1757058","relation":{},"ISSN":["0951-3590","1473-0766"],"issn-type":[{"value":"0951-3590","type":"print"},{"value":"1473-0766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=igye20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=igye20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-07-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}